Honasa Consumer Limited has shared a preliminary performance summary for the quarter ended March 31, 2026. The company anticipates strong growth for the quarter, with business expansion driven by its flagship brand Mamaearth and a successful portfolio of younger brands. The company also confirmed a positive operational start following the integration of BTM Ventures Private Limited, emphasizing sustained profit margins and robust performance in offline distribution channels.
Strong Growth Trajectory
Honasa Consumer Limited expects a robust performance for Q4 FY2026 (January–March 2026). On a business-wide basis, the company is projecting growth in the late twenties. When adjusting for revenue recognition policy changes related to the Flipkart group, the company reports anticipated growth in the early twenties for the quarter.
Brand and Channel Performance
The company’s primary brand, Mamaearth, continues to maintain its growth momentum, with expectations to deliver teens growth during the period. Simultaneously, the company’s younger brands—including The Derma Co., Aqualogica, BBlunt, Dr. Sheth’s, Staze, and Lumineve—are trending upwards with projected growth in the mid-twenties.
Offline distribution remains a critical pillar of this success. Both General Trade and Modern Trade channels are expected to maintain strong growth momentum, supported by expanded distribution coverage across the country.
Strategic Acquisitions and Operational Outlook
This quarter represents the first full period of operations following the acquisition of BTM Ventures Private Limited, which owns the Reginald Men and Molecular Company brands. The integration is performing as expected, contributing to the overall business health.
Looking ahead, Honasa Consumer Limited expects to sustain its current operating profit margin profile. This stability is attributed to disciplined leverage in marketing expenditures and effective management of fixed overheads, even while the company remains proactive in navigating global geopolitical challenges.
Source: BSE
